BioCentury
ARTICLE | Clinical News

Taxoprexin DHA-paclitaxel: Phase III pivotal

October 7, 2002 7:00 AM UTC

Protarga will begin this quarter an international, pivotal Phase III trial comparing Taxoprexin to dacarbazine as a first-line therapy in 560 patients with metastatic melanoma. Patients will receive i...